| Literature DB >> 24527316 |
Gayle M Gordillo1, Stephanie F Bernatchez2, Robert Diegelmann3, Luisa A Di Pietro4, Elof Eriksson5, Boris Hinz6, Harriet W Hopf7, Robert Kirsner8, Paul Liu9, Laura K S Parnell10, George E Sandusky11, Chandan K Sen12, Marjana Tomic-Canic8, Susan W Volk13, Andrew Baird14.
Abstract
SIGNIFICANCE: A review of therapeutic effects in preclinical and clinical studies suggests that concordance between large animal (pig=78%), small laboratory animal (53%) and in vitro (57%) results with those observed in humans is only partial. Pig models of wound healing provide major advantages over other animal models. Since the vast majority of wound-healing research is done in rodents and in vitro, the low concordance rate is a significant impediment to research that will have any clinical impact. CRITICAL ISSUES: To generate clinically relevant experimental data, hypothesis generation should begin, or at least involve human wound tissue samples. Such tissue could be used to test a predetermined hypothesis generated based on, say, murine data. Alternatively, such tissue could be analyzed using high-throughput cell biology techniques (e.g., genomics, proteomics, or metabolomics) to identify novel mechanisms involved in human wounds. Once the hypothesis has been formulated and confirmed using human samples, identification of these same mechanisms in animals represents a valid approach that could be used for more in-depth investigations and experimental manipulations not feasible with humans. FUTURE DIRECTIONS: This consensus statement issued by the Wound Healing Society symposium strongly encourages all wound researchers to involve human wound tissue validation studies to make their animal and cell biology studies more translationally and clinically significant.Entities:
Year: 2013 PMID: 24527316 PMCID: PMC3840478 DOI: 10.1089/wound.2012.0367
Source DB: PubMed Journal: Adv Wound Care (New Rochelle) ISSN: 2162-1918 Impact factor: 4.730